Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension

Expanding consensus in portal hypertension

Roberto de Franchis · Journal of Hepatology · 2015 · 3.1K citations · Full text

Medicine, Internal Medicine, Gastroenterology +16

Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease

Michael Charlton, Gregory T. Everson, Steven L. Flamm et al. · Gastroenterology · 2015 · 799 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Liver stiffness measurement predicts severe portal hypertension in patients with HCV‐related cirrhosis†‡

Francesco Vizzutti, Umberto Arena, Roberto Giulio Romanelli et al. · Hepatology · 2007 · 716 citations · Full text

Medicine, Internal Medicine, Gastroenterology +16

Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial

Michael P. Manns, Didier Samuel, Edward Gane et al. · The Lancet Infectious Diseases · 2016 · 446 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +16

Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis

Cristina Ripoll, Roberto J. Groszmann, Guadalupe García–Tsao et al. · Journal of Hepatology · 2009 · 407 citations

Medicine, Oncology, Carcinogenesis +13